News Archive

Listed below are our archived news items

2013

The European Commission has approved a new vaccine (Bexsero®) that provides broad protection against meningococcal group B disease.

Typhim Vi™ stock is available through Healthcare Logistics.

A new written resource looking at the use of whooping cough vaccine during pregnancy

03 Dec 2012 The end of polio

Polio is 99.7% eradicated and could be completely wiped out within the next two years.

Recently New Zealand was represented during the Global Alliance for Vaccines and Immunisation (GAVI) delegate visit to Myanmar by National List MP Katrina Shanks.

2012

The whooping cough vaccine is available for family/whānau of infants less than one year of age who are already accessing specified immunisation services.

South Canterbury will be commencing a school-based Gardasil® programme for 12 year old girls from term one 2013.

The Centers for Disease Control and Prevention in the US is coordinating a multistate investigation of fungal meningitis among patients who received a particular medication injected into the spine.

Pfizer have announced top-line data assessing immunogenicity, tolerability and safety of Prevenar 13® in adults aged 18-49 years of age.

Toi Te Ora - Public Health Service have children singing about immunisation on radio.

Researchers at the University of Otago are inching closer to the development of the first effective oral vaccine to protect against tuberculosis (TB).

The Ministry of Health has released the updated cold chain management guidelines.

A 49 year old Qatari national has been hospitalised in the UK with a laboratory confirmed novel coronavirus.

The whooping cough vaccine is available free for pregnant women from 20 weeks gestation and new mothers up to two weeks after delivery.

12 Sep 2012 Measles case alert

Measles arrived in Auckland on a flight from Niue on 8 September 2012 and the person visited Middlemore Emergency Department on 9 September 2012.

2011

As of 9 May 2013, GSK have advised that they are continuing to make Rotarix available to patients at a significantly reduced price through the Rotarix patient access programme to at least the end of 2013.

The immunisation programme ended on December 16th 2011. An estimated 31,455 Northlanders are belived to have taken up the offer of free vaccine against the serious disease.

The Ministry of Health declined to fund a nationwide meningococcal C immunisation programme due to the high cost involved.

In New Zealand a single dose of either brand of varicella vaccine in children under the age of 13 years is likely to be adequate because there is a lot of wild virus circulating that will boost immunity.